![](/img/cover-not-exists.png)
Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score â¥50% treated with front-line pembrolizumab
Friedlaender, Alex, Metro, Giulio, Signorelli, Diego, Gili, Alessio, Economopoulou, Panagiota, Roila, Fausto, Banna, Giuseppe, De Toma, Alessandro, Camerini, Andrea, Christopoulou, Athina, Lo Russo, GJournal:
Acta Oncologica
DOI:
10.1080/0284186X.2020.1781249
Date:
June, 2020
File:
PDF, 1.03 MB
2020